HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a Buy rating on Asensus Surgical (AMEX:ASXC) and maintained a $2 price target on the company's stock.
November 15, 2023 | 1:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms a Buy rating on Asensus Surgical with a $2 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $2 price target by a reputable analyst could lead to increased investor confidence and a potential short-term uplift in ASXC's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100